期刊文献+

甲状腺相关性眼病发病机制及动物模型研究

Research on pathogenesis and animal model of thyroid-associated ophthalmopathy
原文传递
导出
摘要 目前甲状腺相关性眼病(thyroid-associated ophthalmopathy,TAO)的病因及发病机制仍不确定,同时缺乏模拟人类TAO疾病的动物模型。促甲状腺激素受体(thyroid stimulating hormone receptor,TSHR)与胰岛素样生长因子-1受体(insulin\|like growth factor-1 receptor,IGF-1R)高表达、免疫细胞及细胞因子激活反应等多因素协同作用可能引起TAO发病;环境和肠道微生物菌群可能诱导TAO动物模型免疫反应的异质性;TSHR质粒体基因免疫电击法建立TAO动物模型,为TAO发病机制和治疗药物研究奠定基础。 The etiology and pathogenesis of thyroid associated ophthahnopathy(TAO)is unclear.Due to the lack of animal models that mimic human TAO disease in a real sense,the research and clinical application of potential therapies based on new theories of pathogenesis are limited.In recent years,it is generally believed that overexpression of thyroid stimulating hormone receptor(TSHR)and insulin-like growth factor-1 receptor(IGF-1R),immune cells and cytokine activation response are the main synergistic factors that cause TAO.Environment and gut microbiome may induce the heterogeneity of immune response in TAO animal models.TSHR plasmid gene immunoelectric shock method established TAO animal model could lay the foundation for the study of TAO pathogenesis and therapeutic drugs.
作者 段春青 孙斌 Duan Chunqing;Sun Bin(Department of Ophthalmology,West Hospital of Second Clinical Hospital of Shanxi Medical University,Taiyuan,030053,China;Shanxi Eye Hospital,Taiyuan,030002,China)
出处 《国际眼科纵览》 2019年第6期421-425,共5页 International Review of Ophthalmology
关键词 甲状腺相关性眼病 动物模型 免疫系统疾病 thyroid-associated ophthalmopathy animal model immune system disease
  • 相关文献

参考文献1

二级参考文献32

  • 1Rege TA,Hagood JS. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration,apoptosis,adhesion,migration,cancer,and fibrosis[J].{H}FASEB JOURNAL,2006.1045-1054.
  • 2Khoo TK,Coenen MJ,Schiefer AR. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves'ophthalmopathy[J].{H}THYROID,2008.1291-1296.
  • 3Smith TJ,Koumas L,Gagnon A. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy[J].{H}Journal of Clinical Endocrinology and Metabolism,2002.385-392.
  • 4Hihi AK,Michalik L,Wahli W. PPARs:transcriptional effectors of fatty acids and their derivatives[J].{H}Cellular and Molecular Life Sciences,2002.790-798.
  • 5Starkey KJ,Janezic A,Jones G. Adipose thyrotrophin receptor expression is elevated in Graves and thyroid eye diseases exvivo and indicates adipogenesis in progress in vivo[J].{H}Journal of Molecular Endocrinology,2003.369-380.
  • 6Lu M,Lin RY. TSH stimulates adipogenesis in mouse embryonic stem cells[J].{H}Journal of Endocrinology,2008.159-169.
  • 7Kumar S,Nadeem S,Stan MN. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy[J].{H}Journal of Molecular Endocrinology,2011.155-163.
  • 8Douglas RS,Afifiyan NF,Hwang C J. Increased generation of fibrocytes in thyroid-associated ophthalmopathy[J].{H}Journal of Clinical Endocrinology and Metabolism,2010.430-438.
  • 9Smith TJ,Tsai CC,Shih M J. Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy[J].{H}THYROID,2008.983-988.
  • 10Douglas RS,Gianoukakis AG,Kamat S. Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis[J].{H}Journal of Immunology,2007.3281-3187.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部